Graybill Wealth Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-60,334
Closed -$2.21M 49
2017
Q3
$2.21M Sell
60,334
-70
-0.1% -$2.83K 1.64% 38
2017
Q2
$2.74M Buy
60,404
+1,219
+2% +$53.8K 2.17% 29
2017
Q1
$2.52M Buy
59,185
+885
+2% +$36.1K 2% 30
2016
Q4
$2.34M Buy
58,300
+1,930
+3% +$74.5K 2% 29
2016
Q3
$2.19M Sell
56,370
-630
-1% -$23.8K 2.03% 30
2016
Q2
$1.97M Sell
57,000
-1,615
-3% -$55.9K 1.82% 34
2016
Q1
$2.02M Buy
58,615
+485
+0.8% +$16.9K 1.83% 31
2015
Q4
$2.25M Sell
58,130
-48,775
-46% -$1.9M 1.94% 32
2015
Q3
$4.18M Buy
106,905
+695
+0.7% +$27.6K 3.43% 1
2015
Q2
$4.04M Sell
106,210
-500
-0.5% -$17.5K 2.99% 4
2015
Q1
$3.52M Buy
106,710
+490
+0.5% +$15K 2.65% 7
2014
Q4
$2.84M Buy
+106,220
New +$2.74M 2.15% 21
2013
Q3
Sell
-122,590
Closed -$2.37M 62
2013
Q2
$2.37M Buy
+122,590
New +$2.56M 2.12% 18

Other funds holding HOLX

Graybill Wealth Management's HOLX Position: Q4 2017 in Review

Graybill Wealth Management sold out of Hologic (HOLX) in Q4 2017, closing a stake of 60,334 shares — an estimated $2.21M sold.

Graybill Wealth Management first reported a position in HOLX in Q2 2013 and held it in 13 quarters. The position peaked at $4.18M in Q3 2015. 472 funds tracked by Wall St. Rank hold HOLX as of Q4 2017.

  • Graybill Wealth Management reported no remaining Hologic position as of Q4 2017 after selling out during the quarter.
  • Graybill Wealth Management sold 60,334 Hologic shares in Q4 2017, an estimated $2.21M.
  • Graybill Wealth Management first reported a position in Hologic in Q2 2013 and held it in 13 quarters.
  • Graybill Wealth Management's Hologic position peaked at $4.18M in Q3 2015.
  • 472 funds tracked by Wall St. Rank held Hologic as of Q4 2017.

Based on Graybill Wealth Management's 13F filing for Q4 2017, filed 16 Jan 2018.